Abstract:The DNA topoisomerase I inhibitors, 10-hydroxycamptothecin (HCPT) and camptothecin (CPT), are indole alkaloids isolated from the Chinese tree, Camptotheca acuminata. They have been shown to have a wide spectrum of anticancer activity both in vitro and in vivo. However, their use has been limited due to their water-insolubility. The purpose of the present study was 2-fold, to determine the in vitro and in vivo activity of HCPT and CPT against human breast cancer and to determine the pharmacokinetics of the two drugs to better understand how they can best be used therapeutically. The bl vitro inhibitory effect on tumor growth was observed with breast cancer cell line MDA-MB-468. The in vivo antitumor effects were then determined using severe combined immunodeficient (SCID) mice bearing MDA-MB-468 xenografts. The tumor-bearing mice were orally administered HCPT (1, 3, 6, 9 mg/kg/day, 5 days per week) or CPT (1, 3, 6 mg/kg/day, 5 days per week) for 3 weeks. Growth of the MDA-MB-468 cells was inhibited by HCPT and CPT in vitro and in vivo in a dose-dependent manner. Complete regression of the tumor xenografts, determined by tumor measurement and microscopic examination, occurred in the groups of animals treated with doses of HCPT or CPT of 3 mg/kg/day or more. In general, HCPT was more effective and less toxic than CPT. To determine the potential mechanisms for the pharmacologic differences, the comparative pharmacokinetics of HCPT and CPT were determined in tumor-bearing SCID mice following i.v. or oral administration of H-3-HCPT or H-3-CPT. Parent drugs and their metabolites in plasma, urine, feces, and various tissues were quantified by a recently developed reversed-phase HPLC method. Significant absorption of both HCPT and CPT was observed after oral administration, with CPT having a higher bioavailability. HCPT and CPT were distributed widely into various tissues including the tumor, enterohepatic system, kidneys, and bone marrow. These studies indicate that HCPT and CPT are of potential use in treatment of breast cancer, providing the basis for the design of future human trials with these anticancer drugs.

Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells

Inhibitory impacts of chemically modified tetracycline-3 and underlying mechanism in human cervical cancer cells.

Anticancer Activity and Radiosensitization of CMT-8 in Human Cervical Cancer HeLa Cells

Novel mechanisms involving chemically modified tetracycline 3 cytotoxicity

Inhibition of Tumor Cell Invasiveness by Chemically Modified Tetracyclines

Anti-migration and anti-invasion effects of 2-hydroxy-6-tridecylbenzoic acid is associated with the enhancement of CYP1B1 expression through activating the AMPK signaling pathway in triple-negative breast cancer cells

Inhibition of invasion and metastasis by DMBT, a novel trehalose derivative, through Akt/GSK-3β/β-catenin pathway in B16BL6 cells.

METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells.

Cryptanshinone Inhibits the Glycolysis and Inhibits Cell Migration Through PKM2/β-Catenin Axis in Breast Cancer

Effect of Marsdenia Tenacissima Extract on G2/M Cell Cycle Arrest by Upregulating 14-3-3σ and Downregulating C-Myc in Vitro and in Vivo

Cetrimonium Bromide Inhibits Cell Migration and Invasion of Human Hepatic SK-HEP-1 Cells Through Modulating the Canonical and Non-canonical TGF-β Signaling Pathways

Antitumor activity and pharmacokinetics following oral administration of natural product DNA topoisomerase I inhibitors 10-hydroxycamptothecin and camptothecin in SCID mice bearing human breast cancer xenografts.

Inhibition of Angiogenesis and Invasion by DMBT is Mediated by Downregulation of VEGF and MMP-9 Through Akt Pathway in MDA-MB-231 Breast Cancer Cells.

DT-13 Inhibits Breast Cancer Cell Migration Via Non-Muscle Myosin II-A Regulation in Tumor Microenvironment Synchronized Adaptations

Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.

Cucurbitacin B Inhibits 12-O-tetradecanoylphorbol 13-Acetate-induced Invasion and Migration of Human Hepatoma Cells Through Inactivating Mitogen-Activated Protein Kinase and Pi3k/Akt Signal Transduction Pathways

Cucurbitacin E Inhibits Breast Tumor Metastasis by Suppressing Cell Migration and Invasion.

[Corrigendum] Next‑generation Sequencing Analysis Reveals That MTH‑3, a Novel Curcuminoid Derivative, Suppresses the Invasion of MDA‑MB‑231 Triple‑negative Breast Adenocarcinoma Cells.

CMTM8 inhibits the carcinogenesis and progression of bladder cancer.

Phytochemicals Potently Inhibit Migration of Metastatic Breast Cancer Cells

Up-regulation of METCAM/MUC18 Promotes Motility, Invasion, and Tumorigenesis of Human Breast Cancer Cells